皮下免疫グロブリン市場-規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

レポートナンバー　0000037177

医薬品原料・製剤

皮下免疫グロブリン市場-規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

Subcutaneous Immunoglobulin Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/01

言語英語

体裁PDF/80ページ

ライセンス/価格80ページ

0000037177

Individual	5,950USD
Team	6,950USD
Enterprise	8,950USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

皮下免疫グロブリン市場-規模、シェア、動向分析レポート:製品タイプ別(IgG、IgA、IgM)、用途別(原発性免疫不全症)、最終用途別、地域別、およびセグメント予測、2024-2030
市場規模と動向
皮下免疫グロブリンの世界市場の規模は、2023年に103億4,000万ドルと評価され、2024年から2030年にかけて9.22%のCAGRで成長すると予想されます。市場は、さまざまな業界参加者による有機的および無機的戦略の採用の増加に牽引され、急速な拡大が見込まれています。2022年1月、 Octapharmaは、ヒトの皮下投与療法であるCutaquigの適応拡大を欧州連合(EU)内で発表しました。この適応症の拡大は、後天性欠乏症に苦しむ幅広い患者に、より柔軟な治療の選択肢を提供します。

レポート詳細

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Application and Distribution Channel Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising prevalence of immunodeficiency diseases
3.4.2. Increasing adoption of immunoglobulin replacement therapy
3.4.3. Rising geriatric population
3.5. Market Restraint Analysis
3.5.1. Cost intensive nature of immunoglobulin replacement therapy
3.5.2. Stringent regulations pertaining to production and approval
3.6. Industry Challenges
3.6.1. Quality assurance and standardization-related challenges
3.6.2. Limited scope for multiple evaluations
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis

Chapter 4. Intravenous Immunoglobulin Market: Segment Analysis by Application, 2018 - 2030 (USD Million)
4.1. Intravenous Immunoglobulin Market: Application Movement Analysis
4.2. Intravenous Immunoglobulin Market: Application Estimates and Forecasts, By Application (USD Million)
4.3. Hypogammaglobulinemia
4.3.1. Hypogammaglobulinemia Market, 2018 - 2030 (USD Million)
4.4. CIPD
4.4.1. CIPD Market, 2018 - 2030 (USD Million)
4.5. Immunodeficiency Diseases
4.5.1. Immunodeficiency Diseases Market, 2018 - 2030 (USD Million)
4.6. Congenital AIDS
4.6.1. Congenital AIDS Market, 2018 - 2030 (USD Million
4.7. Chronic Lymphocytic Leukemia
4.7.1. Chronic Lymphocytic Leukemia Market, 2018 - 2030 (USD Million)
4.8. Leukemia Myasthenia gravis
4.8.1. Myasthenia gravis Market, 2018 - 2030 (USD Million)
4.9. Multifocal motor neuropathy
4.9.1. Multifocal motor neuropathy Market, 2018 - 2030 (USD Million)
4.10. ITP
4.10.1. Leukemia ITP Market, 2018 - 2030 (USD Million)
4.11. Kawasaki disease
4.11.1. Kawasaki Disease Market, 2018 - 2030 (USD Million)
4.12. Guillain-Barre syndrome
4.12.1. Guillain-Barre syndrome Market, 2018 - 2030 (USD Million)
4.13. Others
4.13.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Intravenous Immunoglobulin Market: Segment Analysis by Distribution Channel, 2018 - 2030 (USD Million)
5.1. Intravenous Immunoglobulin Market: Distribution Channel Movement Analysis
5.2. Intravenous Immunoglobulin Market: Distribution Channel Estimates and Forecasts, (USD Million)
5.3. Hospital Pharmacy
5.3.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
5.4. Specialty Pharmacy
5.4.1. Specialty Pharmacy Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Intravenous Immunoglobulin Market: Regional Analysis, 2018 - 2030 (USD Million)
6.1. Intravenous Immunoglobulin Market: Regional Outlook
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. Reimbursement Scenario
6.2.3.6. U.S. Intravenous immunoglobulin Market, 2018 - 2030 (USD MILLION)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Reimbursement Scenario
6.2.4.6. Canada Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. SWOT Analysis
6.3.2. Europe Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. Reimbursement Scenario
6.3.3.6. Germany Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.4. UK
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Reimbursement Scenario
6.3.4.6. UK Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. Reimbursement Scenario
6.3.5.6. France Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Reimbursement Scenario
6.3.6.6. Italy Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Reimbursement Scenario
6.3.7.6. Spain Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Reimbursement Scenario
6.3.8.6. Denmark Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Reimbursement Scenario
6.3.9.6. Sweden Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Target Disease Prevalence
6.3.10.3. Competitive Scenario
6.3.10.4. Regulatory Framework
6.3.10.5. Reimbursement Scenario
6.3.10.6. Norway Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. SWOT Analysis
6.4.2. Asia Pacific Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Reimbursement Scenario
6.4.3.6. Japan Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. Reimbursement Scenario
6.4.4.6. China Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. Reimbursement Scenario
6.4.5.6. India Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Reimbursement Scenario
6.4.6.6. South Korea Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.7. Australia
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Reimbursement Scenario
6.4.7.6. Australia Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.4.8. Thailand
6.4.8.1. Key Country Dynamics
6.4.8.2. Target Disease Prevalence
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.8.5. Reimbursement Scenario
6.4.8.6. Thailand Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. SWOT Analysis
6.5.2. Latin America Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Reimbursement Scenario
6.5.3.6. Brazil Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Reimbursement Scenario
6.5.4.6. Mexico Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.5.5. Reimbursement Scenario
6.5.5.6. Argentina Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. SWOT Analysis
6.6.2. MEA Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. Reimbursement Scenario
6.6.3.6. South Africa Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Reimbursement Scenario
6.6.4.6. Saudi Arabia Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. Reimbursement Scenario
6.6.5.6. UAE Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Competitive Scenario
6.6.6.4. Regulatory Framework
6.6.6.5. Reimbursement Scenario
6.6.6.6. Kuwait Intravenous immunoglobulin Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1 Company Categorization
7.2 Strategy Mapping
7.2.1 NEW PRODUCT LAUNCH
7.2.2 PARTNERSHIPS
7.2.3 ACQUISITION
7.2.4 COLLABORATION
7.2.5 FUNDING
7.3 Key Company Market Share Analysis, 2022
7.4 Company Profiles
7.4.1 Biotest AG
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic Initiatives
7.4.2 Baxter International Inc.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic Initiatives
7.4.3 Octapharma AG
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic Initiatives
7.4.4 LFB Biotechnologies
7.4.4.1 Company overview
7.4.4.2 Product benchmarking
7.4.4.3 Strategic Initiatives
7.4.5 Grifols SA
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic Initiatives
7.4.6 CSL Behring
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic Initiatives
7.4.7 China Biologics Products Inc.
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic Initiatives
7.4.8 Kedrion Biopharma
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic Initiatives
7.4.9 BDI Pharma Inc
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic Initiatives

Chapter 8. KOL Recommendations/ Conclusion

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Intravenous Immunoglobulin Market, by Region, 2018 - 2030 (USD Million)
Table 4. Global Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 5. Global Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 6. North America Intravenous Immunoglobulin Market, by Country, 2018 - 2030 (USD Million)
Table 7. North America Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 8. North America Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 9. U.S. Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 10. U.S. Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 11. Canada Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 12. Canada Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 13. Europe Intravenous Immunoglobulin Market, by Country, 2018 - 2030 (USD Million)
Table 14. Europe Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 15. Europe Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 16. Germany Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 17. Germany Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 18. UK Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 19. UK Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 20. France Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 21. France Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 22. Italy Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 23. Italy Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 24. Spain Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 25. Spain Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 26. Denmark Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 27. Denmark Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 28. Sweden Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 29. Sweden Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 30. Norway Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 31. Norway Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 32. Asia Pacific Intravenous Immunoglobulin Market, by Country, 2018 - 2030 (USD Million)
Table 33. Asia Pacific Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 34. Asia Pacific Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 35. China Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 36. China Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 37. Japan Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 38. Japan Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 39. India Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 40. India Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 41. South Korea Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 42. South Korea Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 43. Australia Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 44. Australia Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 45. Thailand Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 46. Thailand Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 47. Latin America Intravenous Immunoglobulin Market, by Country, 2018 - 2030 (USD Million)
Table 48. Latin America Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 49. Latin America Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 50. Brazil Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 51. Brazil Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 52. Mexico Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 53. Mexico Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 54. Argentina Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 55. Argentina Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Intravenous Immunoglobulin Market, by Country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 59. South Africa Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 60. South Africa Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 61. Saudi Arabia Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 63. UAE Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 64. UAE Intravenous Immunoglobulin Market, By Distribution Channel , 2018 - 2030 (USD Million)
Table 65. Kuwait Intravenous Immunoglobulin Market, by Application, 2018 - 2030 (USD Million)
Table 65. Kuwait Intravenous Immunoglobulin Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig 1. Market research process
Fig 2. Information Procurement
Fig 3. Primary Research Pattern
Fig 4. Market Research Approaches
Fig 5. Value Chain-Based Sizing & Forecasting
Fig 6. Market Formulation & Validation
Fig 7. Intravenous Immunoglobulin, Market Segmentation
Fig 8. Market Snapshot, 2022
Fig 9. Market Trends & Outlook
Fig 10. Market Driver Relevance Analysis (Current & Future Impact)
Fig 11. Market Restraint Relevance Analysis (Current & Future Impact)
Fig 12. Market Challenge Relevance Analysis (Current & Future Impact)
Fig 13. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig 14. Porter’s Five Forces Analysis
Fig 15. Global Intravenous Immunoglobulin Market: By Application Movement Analysis
Fig 16. Global Intravenous Immunoglobulin Market, for Immunodeficiency Diseases, 2018 - 2030 (USD Million)
Fig 17. Global Intravenous Immunoglobulin Market, for CIDP, 2018 - 2030 (USD Million)
Fig 18. Global Intravenous Immunoglobulin Market, for Hypogammaglobulinemia, 2018 - 2030 (USD Million)
Fig 19. Global Intravenous Immunoglobulin Market, for Congenital AIDS, 2018 - 2030 (USD Million)
Fig 20. Global Intravenous Immunoglobulin Market, for Chronic Lymphocytic Leukemia, 2018 - 2030 (USD Million)
Fig 21. Global Intravenous Immunoglobulin Market, for Myasthenia Gravis, 2018 - 2030 (USD Million)
Fig 22. Global Intravenous Immunoglobulin Market, for Multifocal motor neuropathy, 2018 - 2030 (USD Million)
Fig 23. Global Intravenous Immunoglobulin Market, for ITP, 2018 - 2030 (USD Million)
Fig 24. Global Intravenous Immunoglobulin Market, for Kawasaki disease, 2018 - 2030 (USD Million)
Fig 25. Global Intravenous Immunoglobulin Market, for Guillain-Barre syndrome2018 - 2030 (USD Million)
Fig 26. Global Intravenous Immunoglobulin Market, for Others, 2018 - 2030 (USD Million)
Fig 27. Global Intravenous Immunoglobulin Market: Distribution Channel Movement Analysis
Fig 28. Global Intravenous Immunoglobulin Market, for Hospital Pharmacy, 2018 - 2030 (USD Million)
Fig 29. Global Intravenous Immunoglobulin Market, for Specialty Pharmacy, 2018 - 2030 (USD Million)
Fig 30. Global Intravenous Immunoglobulin Market, for Others, 2018 - 2030 (USD Million)
Fig 31. Regional Marketplace: Key Takeaways Intravenous Immunoglobulin Market, Region 2018 - 2030 (USD Million)
Fig 32. Regional Outlook, 2022 & 2030 Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 33. Global Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 34. North America Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 35. U.S. Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 36. Canada Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 37. Europe Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 38. Germany Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 39. UK Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 40. France Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 41. Italy Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 42. Spain Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 43. Denmark Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 44. Sweden Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 45. Norway Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 46. Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 47. Japan Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 48. China Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 49. India Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 50. Australia Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 51. South Korea Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 52. Thailand Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 53. Latin America Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 54. Brazil Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 55. Mexico Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 56. Argentina Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 57. Middle East and Africa Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 58. South Africa Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 59. Saudi Arabia Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 60. UAE Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig 61. Kuwait Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000037177

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。